{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:55:21Z","timestamp":1793465721444,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Reviews in Mutation Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.mrrev.2013.11.001","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T12:30:12Z","timestamp":1385901012000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["The paradox of FGFR3 signaling in skeletal dysplasia: Why chondrocytes growth arrest while other cells over proliferate"],"prefix":"10.1016","volume":"759","author":[{"given":"Pavel","family":"Krejci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrrev.2013.11.001_bib0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jmg.33.9.749","article-title":"Clinical and genetic heterogeneity of hypochondroplasia","volume":"33","author":"Rousseau","year":"1996","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0015","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/316892","article-title":"Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype","volume":"67","author":"Bellus","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0020","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/302275","article-title":"A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene","volume":"64","author":"Tavormina","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0025","first-page":"2519","article-title":"Thanatophoric dwarfism","volume":"75","author":"Maroteaux","year":"1967","journal-title":"Presse Med."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0030","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng0696-233","article-title":"Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia","volume":"13","author":"Naski","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0035","doi-asserted-by":"crossref","first-page":"e3961","DOI":"10.1371\/journal.pone.0003961","article-title":"Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage","volume":"3","author":"Krejci","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0045","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0050","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ng.470","article-title":"Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors","volume":"41","author":"Goriely","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0055","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4161\/cc.5.23.3509","article-title":"FGFR3 mutations in benign skin tumors","volume":"5","author":"Hafner","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0060","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/hmg\/ddi127","article-title":"Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans","volume":"14","author":"Logie","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0070","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood.V97.3.729","article-title":"Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma","volume":"97","author":"Chesi","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0075","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1182\/blood.V95.3.992.003k29_992_998","article-title":"Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis","volume":"95","author":"Plowright","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1158\/1535-7163.MCT-04-0330","article-title":"Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma","volume":"4","author":"Zhu","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0085","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.yexcr.2010.04.021","article-title":"FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes","volume":"316","author":"Hafner","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0090","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/onc.2009.280","article-title":"Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner","volume":"28","author":"di Martino","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0095","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/sj.onc.1203650","article-title":"Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4","volume":"19","author":"Hart","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0100","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood.V97.8.2413","article-title":"The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells","volume":"97","author":"Li","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.21636","article-title":"Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias","volume":"33","author":"Foldynova-Trantirkova","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0110","first-page":"368","article-title":"Achondroplasia is defined by recurrent G380R mutations of FGFR3","volume":"56","author":"Bellus","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0115","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01241398-198909010-00002","article-title":"Limb lengthening for achondroplasia: early experience","volume":"9","author":"Price","year":"1989","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/eje.0.1380275","article-title":"Effect of growth hormone therapy in children with achondroplasia: growth pattern, hypothalamic\u2013pituitary function, and genotype","volume":"138","author":"Tanaka","year":"1998","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0125","first-page":"4033","article-title":"Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia","volume":"81","author":"Shohat","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1507\/endocrj.50.69","article-title":"The comparison of the effects of short-term growth hormone treatment in patients with achondroplasia and with hypochondroplasia","volume":"50","author":"Tanaka","year":"2003","journal-title":"Endocr. J."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00774-003-0425-7","article-title":"Efficacy of growth hormone therapy for patients with skeletal dysplasia","volume":"21","author":"Kanazawa","year":"2003","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0140","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1126\/science.276.5314.955","article-title":"Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors","volume":"276","author":"Mohammadi","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2012.07.001","article-title":"Anticancer molecules targeting fibroblast growth factor receptors","volume":"33","author":"Liang","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0150","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1158\/0008-5472.CAN-10-2700","article-title":"E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models","volume":"71","author":"Bello","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0155","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1182\/blood-2007-02-074286","article-title":"Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome","volume":"110","author":"Chase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0160","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ctrv.2011.07.008","article-title":"The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors","volume":"38","author":"Scagliotti","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd3073","article-title":"Pazopanib","volume":"9","author":"Bukowski","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0170","first-page":"443","article-title":"Pazopanib: the newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma","volume":"71","author":"Keisner","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ymgme.2007.06.014","article-title":"C-natriuretic peptide: an important regulator of cartilage","volume":"92","author":"Pejchalova","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1346.002","article-title":"PTHrP and skeletal development","volume":"1068","author":"Kronenberg","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"Suppl. 3","key":"10.1016\/j.mrrev.2013.11.001_bib0185","first-page":"60","article-title":"Molecular basis for the treatment of achondroplasia","volume":"60","author":"Yamanaka","year":"2003","journal-title":"Horm. Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0190","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/hmg\/10.5.457","article-title":"A Ser(365)\u2192Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh\/PTHrP signals and causes severe achondroplasia","volume":"10","author":"Chen","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2007.02.028","article-title":"PTH has the potential to rescue disturbed bone growth in achondroplasia","volume":"41","author":"Ueda","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0200","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.molcel.2004.11.055","article-title":"Regulation of Raf-1 by direct feedback phosphorylation","volume":"17","author":"Dougherty","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1091\/mbc.10.1.23","article-title":"Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis","volume":"10","author":"Dell\u2019Era","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1359-6101(00)00014-9","article-title":"FGF signals for cell proliferation and migration through different pathways","volume":"11","author":"Boilly","year":"2000","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0220","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1242\/dev.128.24.5075","article-title":"FGF-induced lens cell proliferation and differentiation is dependent on MAPK (ERK1\/2) signalling","volume":"128","author":"Lovicu","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0225","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1165\/rcmb.2003-0406OC","article-title":"Keratinocyte growth factor stimulates alveolar type II cell proliferation through the extracellular signal-regulated kinase and phosphatidylinositol 3-OH kinase pathways","volume":"30","author":"Portnoy","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0230","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jcp.20483","article-title":"Ligand concentration is a driver of divergent signaling and pleiotropic cellular responses to FGF","volume":"206","author":"Garcia-Maya","year":"2006","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcp.20437","article-title":"MEK hyperphosphorylation coincides with cell cycle shut down of cultured smooth muscle cells","volume":"206","author":"Vogel","year":"2006","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0240","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1460-9568.2007.05336.x","article-title":"Mechanism of insulin-like growth factor I-mediated proliferation of adult neural progenitor cells: role of Akt","volume":"25","author":"Kalluri","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0245","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00441-011-1284-5","article-title":"IL-17 and FGF signaling involved in mouse mesenchymal stem cell proliferation","volume":"346","author":"Mojsilovic","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0250","first-page":"357","article-title":"Fibroblast growth factor-1-induced ERK1\/2 signaling reciprocally regulates proliferation and smooth muscle cell differentiation of ligament-derived endothelial progenitor cell-like cells","volume":"29","author":"Takahashi","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0255","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccr.2007.08.003","article-title":"FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK\/ERK pathway","volume":"12","author":"Kang","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0260","doi-asserted-by":"crossref","first-page":"28087","DOI":"10.1074\/jbc.M112.377218","article-title":"Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)\/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma","volume":"287","author":"Yadav","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0265","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1038\/sj.onc.1206798","article-title":"The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3","volume":"22","author":"Agazie","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0270","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1038\/sj.onc.1208782","article-title":"Accelerated proliferation of myeloma cells by interleukin-6 cooperating with fibroblast growth factor receptor 3-mediated signals","volume":"24","author":"Ishikawa","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0275","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.yexcr.2004.03.011","article-title":"FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells","volume":"297","author":"Krejci","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0280","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1242\/jcs.02618","article-title":"Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis","volume":"118","author":"Krejci","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0285","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1074\/jbc.M606144200","article-title":"Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins","volume":"282","author":"Krejci","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0290","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1242\/jcs.017160","article-title":"STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes","volume":"121","author":"Krejci","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0295","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1074\/jbc.M310384200","article-title":"Activation of the ERK1\/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes","volume":"279","author":"Raucci","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0300","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/hmg\/ddi161","article-title":"Sustained ERK1\/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells","volume":"14","author":"Nowroozi","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0305","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0310","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.200302075","article-title":"A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation","volume":"161","author":"Dailey","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0315","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/hmg\/ddn339","article-title":"FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway","volume":"18","author":"Matsushita","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0325","doi-asserted-by":"crossref","first-page":"29347","DOI":"10.1074\/jbc.M101859200","article-title":"Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2","volume":"276","author":"Aikawa","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0330","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1038\/sj.onc.1207331","article-title":"Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins","volume":"23","author":"Koziczak","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0335","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1158\/0008-5472.CAN-08-2816","article-title":"Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer","volume":"69","author":"Tomlinson","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0340","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1073\/pnas.94.2.448","article-title":"Cell cycle arrest mediated by the MEK\/mitogen-activated protein kinase pathway","volume":"94","author":"Pumiglia","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0345","doi-asserted-by":"crossref","first-page":"30841","DOI":"10.1074\/jbc.270.52.30841","article-title":"Nerve growth factor-induced growth arrest and induction of p21Cip1\/WAF1 in NIH-3T3 cells expressing TrkA","volume":"270","author":"Decker","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0350","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1128\/MCB.17.9.5588","article-title":"High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1","volume":"17","author":"Sewing","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0355","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/1521-1878(200009)22:9<818::AID-BIES7>3.0.CO;2-6","article-title":"Integrating the MAP kinase signal into the G1 phase cell cycle machinery","volume":"22","author":"Roovers","year":"2000","journal-title":"Bioessays"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0360","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gde.2009.04.001","article-title":"The RASopathies: developmental syndromes of Ras\/MAPK pathway dysregulation","volume":"19","author":"Tidyman","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0365","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.8493579","article-title":"Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2","volume":"260","author":"Chardin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0370","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1073\/pnas.85.14.5026","article-title":"Purification of ras GTPase activating protein from bovine brain","volume":"85","author":"Gibbs","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0375","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0380","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/35088082","article-title":"Spred is a Sprouty-related suppressor of Ras signalling","volume":"412","author":"Wakioka","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0385","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1101\/gad.190876.112","article-title":"A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1","volume":"26","author":"Stowe","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0390","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajmg.c.30296","article-title":"The musculoskeletal phenotype of the RASopathies","volume":"157","author":"Stevenson","year":"2011","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0395","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1073\/pnas.1016933108","article-title":"Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome","volume":"108","author":"Urosevic","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0400","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0405","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1172\/JCI43910","article-title":"Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome-associated Sos1 mutation","volume":"120","author":"Chen","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"15","key":"10.1016\/j.mrrev.2013.11.001_bib0410","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddt162","article-title":"The Ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation","volume":"22","author":"Ono","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0415","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/dbio.1993.1040","article-title":"Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis","volume":"155","author":"Peters","year":"1993","journal-title":"Dev. Biol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0425","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0430","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome","volume":"38","author":"Niihori","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0435","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.30065","article-title":"Tumor predisposition in Costello syndrome","volume":"137C","author":"Gripp","year":"2005","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0440","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.20748","article-title":"The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders","volume":"29","author":"Aoki","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0445","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajmg.c.30300","article-title":"Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes","volume":"157","author":"Kratz","year":"2011","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0450","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1074\/jbc.271.6.3229","article-title":"Signal transduction pathways regulated by mitogen-activated\/extracellular response kinase kinase kinase induce cell death","volume":"271","author":"Johnson","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0455","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1101\/gad.12.19.2997","article-title":"Senescence of human fibroblasts induced by oncogenic Raf","volume":"12","author":"Zhu","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0460","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a","volume":"88","author":"Serrano","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0465","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: mechanisms of ERK-induced cell death \u2013 apoptosis, autophagy and senescence","volume":"277","author":"Cagnol","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0470","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0475","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bone.2010.03.021","article-title":"FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence","volume":"47","author":"Krejci","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0480","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1093\/hmg\/ddp195","article-title":"The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects","volume":"18","author":"Ota","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0485","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1158\/0008-5472.840.65.3","article-title":"Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells","volume":"65","author":"Trost","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0490","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.cdd.4401465","article-title":"Paraptosis: mediation by MAP kinases and inhibition by AIP-1\/Alix","volume":"11","author":"Sperandio","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0495","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1541-7786.MCR-12-0456","article-title":"Inhibition of TWIST1 leads to activation of oncogene-induced senescence in oncogene-driven non-small cell lung cancer","volume":"11","author":"Burns","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0500","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cell.2006.11.050","article-title":"PRAK is essential for ras-induced senescence and tumor suppression","volume":"128","author":"Sun","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0505","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2007.01.005","article-title":"Oncogene-induced senescence pathways weave an intricate tapestry","volume":"128","author":"Yaswen","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0510","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature05268","article-title":"Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints","volume":"444","author":"Bartkova","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0515","doi-asserted-by":"crossref","first-page":"10968","DOI":"10.1073\/pnas.0611638104","article-title":"ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence","volume":"104","author":"Ha","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0520","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3727\/0963689109X546562","article-title":"Cell contact accelerates replicative senescence of human mesenchymal stem cells independent of telomere shortening and p53 activation: roles of Ras and oxidative stress","volume":"20","author":"Ho","year":"2011","journal-title":"Cell Transplant."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0525","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1101\/gad.203984.112","article-title":"Tumor suppressor activity of the ERK\/MAPK pathway by promoting selective protein degradation","volume":"27","author":"Deschenes-Simard","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0530","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.4161\/cc.20944","article-title":"Overexpression of cyclin E\/CDK2 complexes overcomes FGF-induced cell cycle arrest in the presence of hypophosphorylated Rb proteins","volume":"11","author":"Kolupaeva","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0535","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2003.09.002","article-title":"Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias","volume":"34","author":"Legeai-Mallet","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0540","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI6690","article-title":"Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis","volume":"104","author":"Chen","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0545","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0550","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0555","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/436642a","article-title":"Tumour biology: senescence in premalignant tumours","volume":"436","author":"Collado","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0560","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1073\/pnas.0912629107","article-title":"Rate, molecular spectrum, and consequences of human mutation","volume":"107","author":"Lynch","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0565","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/MCB.20.2.516-522.2000","article-title":"The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation","volume":"20","author":"Monsonego-Ornan","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0570","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0925-4773(98)00133-6","article-title":"Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification","volume":"77","author":"Delezoide","year":"1998","journal-title":"Mech. Dev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0575","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0580","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1073\/pnas.0607879104","article-title":"Predicting protein\u2013protein interactions based only on sequences information","volume":"104","author":"Shen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0585","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1756-185X.2009.01390.x","article-title":"Angiogenic growth factors inhibit chondrocyte ageing in osteoarthritis: potential involvement of catabolic stress-induced overexpression of caveolin-1 in cellular ageing","volume":"12","author":"Yudoh","year":"2009","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0590","doi-asserted-by":"crossref","first-page":"27789","DOI":"10.1074\/jbc.M208105200","article-title":"Senescent phenotype can be reversed by reduction of caveolin status","volume":"278","author":"Cho","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0595","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0600","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1615\/CritRevOncog.v17.i1.70","article-title":"Aberrant B-Raf signaling in human cancer \u2013 10 years from bench to bedside","volume":"17","author":"Roring","year":"2012","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0605","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.oraloncology.2011.12.006","article-title":"Ras oncogenes in oral cancer: the past 20 years","volume":"48","author":"Murugan","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0610","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc1503","article-title":"Targeting the mitogen-activated protein kinase cascade to treat cancer","volume":"4","author":"Sebolt-Leopold","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0615","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0620","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/pdp.22.1.87.103","article-title":"Mouse models orthologous to FGFR3-related skeletal dysplasias","volume":"22","author":"Brodie","year":"2003","journal-title":"Pediatr. Pathol. Mol. Med."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0625","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/422013","article-title":"Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux","volume":"75","author":"Bartels","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0630","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1098-1004(1999)14:2<115::AID-HUMU3>3.0.CO;2-2","article-title":"Clinical spectrum of fibroblast growth factor receptor mutations","volume":"14","author":"Passos-Bueno","year":"1999","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0635","doi-asserted-by":"crossref","first-page":"11012","DOI":"10.1073\/pnas.88.24.11012","article-title":"Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation","volume":"88","author":"Stein","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0640","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/MCB.22.10.3389-3403.2002","article-title":"Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3\/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence","volume":"22","author":"Wang","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0645","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.0507979103","article-title":"Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0650","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0047-6374(95)93703-6","article-title":"Enhanced expression of cyclin D1 in senescent human fibroblasts","volume":"81","author":"Fukami","year":"1995","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0655","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1038\/sj.onc.1205525","article-title":"Identification of novel candidates for replicative senescence by functional proteomics","volume":"21","author":"Benvenuti","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0660","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1128\/MCB.22.21.7385-7397.2002","article-title":"Induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1","volume":"22","author":"Benanti","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0665","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1074\/jbc.M908162199","article-title":"Up-regulation of caveolin attenuates epidermal growth factor signaling in senescent cells","volume":"275","author":"Park","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0670","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/excr.2001.5434","article-title":"Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence","volume":"273","author":"Barradas","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0675","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/excr.1998.3948","article-title":"Cloning and identification of genes that associate with mammalian replicative senescence","volume":"240","author":"Gonos","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0680","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0021-9258(17)42146-6","article-title":"Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts","volume":"269","author":"Hara","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0685","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ccr.2006.10.003","article-title":"A negative feedback signaling network underlies oncogene-induced senescence","volume":"10","author":"Courtois-Cox","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0690","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cellsig.2008.04.001","article-title":"Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia","volume":"20","author":"Guo","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0695","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1158\/1541-7786.MCR-07-0114","article-title":"Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts","volume":"6","author":"Li","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0700","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cellsig.2008.10.006","article-title":"Fibroblast growth factor inhibits interferon gamma-STAT1 and interleukin 6-STAT3 signaling in chondrocytes","volume":"21","author":"Krejci","year":"2009","journal-title":"Cell Signal."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0705","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-59745-361-5_3","article-title":"Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay","volume":"371","author":"Itahana","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0710","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0014-4827(90)90028-9","article-title":"Fibronectin and collagen gene expression during in vitro ageing of pig skin fibroblasts","volume":"191","author":"Martin","year":"1990","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0715","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.1320210402","article-title":"The role of mesenchyme-like tissue in the pathogenesis of thanatophoric dysplasia","volume":"21","author":"Ornoy","year":"1985","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0720","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"Eswarakumar","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0725","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1242\/jcs.01635","article-title":"Stromal\u2013epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation","volume":"118","author":"Parrinello","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0730","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S1357-2725(02)00053-5","article-title":"Cancer and aging: a model for the cancer promoting effects of the aging stroma","volume":"34","author":"Krtolica","year":"2002","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.mrrev.2013.11.001_bib0735","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/sj.onc.1209049","article-title":"Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells","volume":"25","author":"Ota","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.mrrev.2013.11.001_bib0740","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/(SICI)1096-8628(19960517)63:2<401::AID-AJMG15>3.0.CO;2-O","article-title":"In vitro studies on clonal growth of chondrocytes in thanatophoric dysplasia","volume":"63","author":"Brenner","year":"1996","journal-title":"Am. J. Med. Genet."}],"container-title":["Mutation Research\/Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574213000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574213000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:15:39Z","timestamp":1761300939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574213000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":148,"alternative-id":["S1383574213000902"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2013.11.001","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The paradox of FGFR3 signaling in skeletal dysplasia: Why chondrocytes growth arrest while other cells over proliferate","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2013.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}